Novel Rapamycin Derivative With Lower Immunosuppressive Activity and Cytotoxicity Extends Lifespan of Caenorhabditis elegans
Journal of Applied Toxicology · 2026-12 · 46 (12) · 4656-4668
DOI: 10.1002/jat.70225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 30.04.2026. Verfasst von Kualiang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Longevity, Sirolimus, Immunosuppressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Fujian Provincial Department of Science and Technology.
Abstract (Originalsprache)
Rapamycin is a multifunctional drug derived from Streptomyces hydroscopicus with several biological activities, such as anti‐fungal, anti‐tumor, anti‐proliferation, and immunosuppressive activities. In recent years, rapamycin and its derivatives have attracted widespread attention in the field of lifespan extension or anti‐aging. In view of the strong immunosuppressive activity and certain cytotoxicity of rapamycin itself, it may cause some potential adverse reactions for long‐term use. In this study, a rapamycin derivative with lower immunosuppressive activity and cytotoxicity was selected for further study. Based on the analysis of lifespan extension, the rapamycin thiazole‐derivative FIM‐X8 showed a strong effect on extending the lifespan of Caenorhabditis elegans . The influences on the survival of nematodes under high temperature or oxidation conditions were also analyzed. Further studies on the longevity‐associated genes showed that lifespan extension induced by rapalogs was comprehensively regulated by multiple metabolic pathways, and it was closely related to the key role of mTOR in the regulation of growth and metabolism. Genes rsks‐1 and daf‐12 mutant nematode strains were selected to elucidate the mechanism of lifespan extension, and we found that great importance was attached to gene rsks‐1 when FIM‐X8 extended the lifespan of C. elegans .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian, China.
- School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
ORCID-Profile: Lijun Xie
Förderung
- Fujian Provincial Department of Science and Technology
Zitieren
APA
Li, K., Li, Q., Xie, L., Ying, J., Chen, X., Liu, Y., & Yang, G. (2026). Novel Rapamycin Derivative With Lower Immunosuppressive Activity and Cytotoxicity Extends Lifespan of Caenorhabditis elegans. Journal of Applied Toxicology, 46(12), 4656-4668. https://doi.org/10.1002/jat.70225
Vancouver
Li K, Li Q, Xie L, Ying J, Chen X, Liu Y, et al. Novel Rapamycin Derivative With Lower Immunosuppressive Activity and Cytotoxicity Extends Lifespan of Caenorhabditis elegans. Journal of Applied Toxicology. 2026;46(12):4656-4668. doi:10.1002/jat.70225
BibTeX
@article{Li2026,
author = {Li, Kualiang and Li, Qingqin and Xie, Lijun and Ying, Jiayin and Chen, Xiaqin and Liu, Ying and Yang, Guoxin},
title = {Novel Rapamycin Derivative With Lower Immunosuppressive Activity and Cytotoxicity Extends Lifespan of Caenorhabditis elegans},
journal = {Journal of Applied Toxicology},
year = {2026},
volume = {46},
number = {12},
pages = {4656--4668},
doi = {10.1002/jat.70225}
}
EUVIMED